Role of Procalcitonin in Intracerebral Hemorrhage Stroke with COVID-19
Downloads
Introduction: As COVID-19 has rapidly spread worldwide, it is an urgent health problem. Some evidence suggests that SARS-CoV-2 also affects the central nervous system. Stroke is the most common disease of the central nervous system. In contrast to ischemic stroke, which can occur due to the hypercoagulation effect of COVID-19, the study of Intracerebral Hemorrhage (ICH) associated with COVID-19 is still unclear. Objective: This paper investigated the characteristics of an inflammatory biomarker and compared the outcomes of ICH patients with COVID-19 and ICH patients without COVID-19. Methods: We conducted a retrospective, observational analysis case-control of patients (n = 42) admitted with ICH with positive COVID-19 and ICH with negative COVID-19 at the National Brain Center Hospital Prof.Dr.dr. Mahar Mardjono from March 2020 to August 2021. We took blood samples and COVID-19 swab PCR on the first day of admission, and GOS was measured when the patients were discharged. Results: There were 21 ICH patients with positive COVID-19 who had a significantly procalcitonin (p < 0.05) compared to control patients. From Spearman's correlational analysis, there is a significant value between early procalcitonin and the Barthel Index (rs = -0,374, p < 0.05), early CRP and GOS (rs =- 0.329, p < 0.05), which indicates weak-inverse correlation, and between early PCT and GOS (rs = -0.438, p < 0.05) which indicates moderate-inverse correlation. Conclusion: The level of procalcitonin was increased in ICH patients with COVID-19. Maybe PCT could be a predictor of outcome in ICH patients with COVID-19.
Yachou Y, El IDrissi A, Belapasov V, Benali S. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: Understanding the neurological manifestations in COVID-19 patients. Neurol Sci. 2020;41(10):2657–69.
Wang H, Tang X, Fan H, Luo Y, Song Y, Xu Y, et al. Potential mechanisms of hemorrhagic stroke in elderly COVID-19 patients. Aging (Albany NY). 2020;12(11):10022–34.
Spence J, de Freitas G, Pettigrew L, Ay H, Liebeskind D, Kase C, et al. Mechanisms of stroke in COVID-19. Cerebrovasc Dis. 2020;49:451–8.
Bermejo-Martin J, Almansa R, Torres A, Gonzales-Rivera M, Kelvin D. COVID-19 as a cardiovascular disease: The potential role of chronic endothelial dysfunction. Cardiovasc Res. 2020;116(10):e132–3.
Cheruiyot I, Sehmi P, Ominde B, Bundi P, Mislani M, Ngure B, et al. Intracranial hemorrhage in coronavirus disease 2019 (COVID-19) patients. Neurol Sci. 2021;42(1):25–33.
Owolabi L, Raafat A, Enwere O, Mustapha A, Adamu B, AlGhamdi M. Hemorrhagic infarctive stroke in COVID-19 patients: Report of two cases and review of the literature. J Community Hosp Intern Med Perspect. 2021;11(3):322–6.
Channappanavar R, Perlman S. Pathogenic human coronavirus infections: Causes and consequences of cytokine storm and immunopathology. Semin Immunopathol.2017;39(5):529–39.
Zhang F, Ren Y, Shi Y, Fu W, Tao C, Li X, et al. Predictive ability of admission neutrophil to lymphocyte ratio on short-term outcome in patients with spontaneous cerebellar hemorrhage. Med. 2019;98(25):e16120.
Shiferaw B, Bekele E, Kumar K, Boutin A, Frieri M. The role of procalcitonin as a biomarker in sepsis. J Inf Dis Epid. 2016;2(1):1–4.
An P, Zhu Y, Yang L. Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications. Pharmacol Res. 2020;159:104946.
Huang I, Pranata R, Lim M, Oehadian A, Alisjahbana B. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: A meta-analysis. Ther Adv Respir Dis. 2020;14:1–14.
Olwal C, Nganyewo N, Tapela K, Zune A, Owoicho O, Bediako Y, et al. Parallels in sepsis and COVID-19 conditions: Implications for managing severe COVID-19. Front Immunol. 2021;12:602848.
Feng T, James A, Doumlele K, White S, Twardzik W, Zahid K, et al. Procalcitonin levels in COVID-19 patients are strongly associated with mortality and ICU acceptance in an underserved, inner city population. American Journal of Respiratory and Critical Care Medicine. 2021;57(10):1070.
Jain S, Sinha S, Sharma S, Samantaray J, Aggrawal P, Vikram N, et al. Procalcitonin as a prognostic marker for sepsis: a prospective observational study. BMC Res Notes. 2014;7:1–7.
Copyright (c) 2022 Ita Muharram Sari, Iswandi Erwin, Fiizhda Baqarizky, Puspa Oktaviani, Sardiana Salam, Anna Mardiana Ritonga
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
